High ovarian responders have the highest risk of premature progesterone rise.

IF 1.8 Q3 OBSTETRICS & GYNECOLOGY Jornal Brasileiro de Reproducao Assistida Pub Date : 2024-06-01 DOI:10.5935/1518-0557.20240004
Alfredo Cortés-Vazquez, Greys Thelma Vásquez-Ramírez, Alfredo Leonardo Cortés-Algara, Jesús-Daniel Moreno-García, Panagiotis Drakopoulos
{"title":"High ovarian responders have the highest risk of premature progesterone rise.","authors":"Alfredo Cortés-Vazquez, Greys Thelma Vásquez-Ramírez, Alfredo Leonardo Cortés-Algara, Jesús-Daniel Moreno-García, Panagiotis Drakopoulos","doi":"10.5935/1518-0557.20240004","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Late follicular phase progesterone elevation is a complication that affects approximately 38% of IVF cycles. There is a lack of consensus on the appropriate cut-off levels for progesterone on hCG day. Although premature progesterone rise occurs in all kinds of ovarian responses, there is a knowledge gap regarding the ovarian response with the highest risk of this phenomenon. Our study aims to assess the relative risk of each kind of ovarian response for premature progesterone rise and evaluate the prevalence of premature progesterone rise in each ovarian response.</p><p><strong>Methods: </strong>A retrospective, cross-sectional, comparative and analytic study was performed at the Reproductive Endocrinology Department in Centro Médico Nacional 20 de Noviembre in Mexico City. All conventional-antagonist cycles were grouped according to their ovarian response and were evaluated from 2015 to 2020. Pearson's Squared-chi, Cramer's V, cross-table and the relative risk were calculated.</p><p><strong>Results: </strong>The prevalence of premature progesterone rise oscillated from 20.8 to 67.9% for low and high ovarian responders, respectively. After calculating the relative risk, high ovarian responders had a 1.38 higher risk for premature progesterone rise than other groups.</p><p><strong>Conclusions: </strong>High ovarian responders have the highest risk for premature progesterone rise compared to normal and low ovarian responders. High ovarian responders have a 67.9% prevalence of premature progesterone rise.</p>","PeriodicalId":46364,"journal":{"name":"Jornal Brasileiro de Reproducao Assistida","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11152415/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jornal Brasileiro de Reproducao Assistida","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5935/1518-0557.20240004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Late follicular phase progesterone elevation is a complication that affects approximately 38% of IVF cycles. There is a lack of consensus on the appropriate cut-off levels for progesterone on hCG day. Although premature progesterone rise occurs in all kinds of ovarian responses, there is a knowledge gap regarding the ovarian response with the highest risk of this phenomenon. Our study aims to assess the relative risk of each kind of ovarian response for premature progesterone rise and evaluate the prevalence of premature progesterone rise in each ovarian response.

Methods: A retrospective, cross-sectional, comparative and analytic study was performed at the Reproductive Endocrinology Department in Centro Médico Nacional 20 de Noviembre in Mexico City. All conventional-antagonist cycles were grouped according to their ovarian response and were evaluated from 2015 to 2020. Pearson's Squared-chi, Cramer's V, cross-table and the relative risk were calculated.

Results: The prevalence of premature progesterone rise oscillated from 20.8 to 67.9% for low and high ovarian responders, respectively. After calculating the relative risk, high ovarian responders had a 1.38 higher risk for premature progesterone rise than other groups.

Conclusions: High ovarian responders have the highest risk for premature progesterone rise compared to normal and low ovarian responders. High ovarian responders have a 67.9% prevalence of premature progesterone rise.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
卵巢反应性高的人孕酮过早升高的风险最高。
目的卵泡晚期孕酮升高是一种并发症,影响到约 38% 的试管婴儿周期。关于 hCG 日孕酮的适当临界水平,目前还缺乏共识。虽然孕酮过早升高会发生在各种卵巢反应中,但关于发生这种现象风险最高的卵巢反应,目前还存在知识空白。我们的研究旨在评估每种卵巢反应发生孕酮过早升高的相对风险,并评估每种卵巢反应中孕酮过早升高的发生率:方法:我们在墨西哥城国立 20 de Noviembre 中心生殖内分泌科进行了一项回顾性、横断面、比较和分析研究。根据卵巢反应对所有常规拮抗剂周期进行了分组,并从 2015 年至 2020 年对其进行了评估。计算了皮尔逊方差、Cramer's V、交叉表和相对风险:低卵巢反应者和高卵巢反应者孕酮过早升高的发生率分别为 20.8%至 67.9%。计算相对风险后,高卵巢反应者孕酮过早升高的风险比其他组别高 1.38:结论:与正常和低卵巢反应者相比,高卵巢反应者孕酮过早升高的风险最高。高卵巢反应者孕酮过早升高的发生率为 67.9%。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.30
自引率
6.70%
发文量
56
期刊最新文献
Deleterious Effects of Caffeine Consumption on Reproductive Functions of Female Wistar Rats. Effect of β-caryophyllene on Sperm Cryopreservation. Poster Presentation - REDLARA Congress Andean Region 2024 - Santiago - Chile. The effect of single dose of gonadotropin-releasing hormone agonist injection in frozen-thawed embryo transfer on pregnancy outcomes: A systematic review and meta-analysis. Effects of astaxanthin supplementation during vitrification and liquid nitrogen vapor freezing on motility, morphology, survival, reactive oxygen species (ROS), and DNA fragmentation of post-cryopreserved human sperm.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1